Skip to main content

Table 1 Patient clinicopathological characteristics

From: Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers

 

n =69

Age (year)

 median

56

 range

27–89

Tumor size (mm)

  < 20

23

  ≥ 20

35

 unknown

11

Lymph node invasion

 yes

15

 no

38

 unknown

16

Ki 67 (%)

  < 20

11

  ≥ 20

52

 unknown

6

Histology

 IDC

47

 other

19

 unknown

3

Bloom

 I

6

 II

7

 III

53

 unknown

3

Molecular subtype

 ck5/6 +, ER-, Her2-

30

 ck5/6 -, ER-, Her2-

32

 unknown

7

Relapse

 yes

24

 no

45